An Acid Response IR780-Based Targeted Nanoparticle for Intraoperative Near-Infrared Fluorescence Imaging of Ovarian Cancer
Jiao Song,Huixia Ye,Senwei Jiang,Yuebo Yang,Xiaomao Li
DOI: https://doi.org/10.2147/IJN.S375145
IF: 7.033
2022-10-20
International Journal of Nanomedicine
Abstract:Jiao Song, &ast Huixia Ye, &ast Senwei Jiang, Yuebo Yang, Xiaomao Li Gynaecology Department, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuebo Yang; Xiaomao Li, Gynaecology Department, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, People's Republic of China, Tel/Fax +86 20-85252259 ; +86 20-85253289, Email ; Introduction: Complete resection of all visible disease (R0 resection) is critical for the treatment of ovarian cancer patients, and accurate real-time guidance provided by intraoperative near-infrared (NIR) fluorescence images is beneficial for achieving complete resection of all visible disease. Methods: Based on the optical properties of IR780 and the characteristics of the acidic tumor microenvironment, we develop a new smart nanoparticle (eg, FA-IR780&PFOB-SNPs) by using the pH response nano framework (FA-PEG-PLGA-PEOz) and adjusting the amount of IR780. The FA-IR780&PFOB-SNPs was characterized for morphology, microstructure, particle size, pH-response, drug-loading efficiency and biological safety. The ultraclear fluorescence Navigation Endoscopy System was applied to evaluate the tumor recognition of FA-IR780&PFOB-SNPs in vivo. Results: The structure of FA-IR780&PFOB-SNPs was stable in a neutral environment, and the near-infrared (NIR) fluorescence was turned off, while the structure of FA-IR780&PFOB-SNPs was degraded in the acidic tumour microenvironment, and the NIR fluorescence was turned on. Through the ovarian subcutaneous xenograft tumour and ovarian intraperitoneal xenograft tumour models, it was confirmed that FA-IR780&PFOB-SNPs could clearly display the boundaries of abdominal micron-sized tumours through near-infrared fluorescence imaging, with a TBR greater than 5. Conclusion: The FA-IR780&PFOB-SNPs have the potential to provide to ovarian cancer intraoperative near infrared fluorescence navigation during precision tumour resection to achieve R0 and improve the prognosis of ovarian cancer patients. Keywords: near-infrared fluorescence imaging, IR780 iodide, epithelial ovarian cancer, tumour-activatable nanoparticles Epithelial ovarian cancer is the leading cause of cancer-related death in gynaecology patients. 1 Due to a lack of effective screening options and specific warning signs, over 75% of patients are diagnosed with stage III/IV disease. Surgery is the cornerstone in the initial treatment of ovarian cancer. 2 It was reported that the median survival time of patients who undergo complete resection of all visible disease (R0) is 99.1 months, and the corresponding durations for patients with residuals of 0.1–1 cm or >1 cm are 36.2 or 29.6 months, respectively. 3 Additionally, the lower residual tumour load that is obtained by using optimal cytoreductive surgery can improve subsequent systemic treatments, including chemotherapy and molecular targeted therapy (poly(ADP-ribose) polymerase (PARP) inhibitors). 4 However, it has been difficult to achieve R0 by relying solely on palpation and visual inspection by surgeons. Moreover, surgeons always underestimate residual disease; despite complete surgery, early postoperative computerized tomography detects suboptimal (>1 cm) residual tumours in almost half of patients. 5 In recent years, some preclinical and clinical studies have shown that fluorescent-guided surgery (FGS, use of tumour-targeted fluorescent dyes to illuminate malignant tissue and thereby facilitate its surgical resection) has promise for decreasing residual tumours and improving patient outcomes. 6 Indocyanine green (ICG), a near-infrared fluorescent dye already in clinical use, has been shown to successfully detect metastatic sentinel lymph nodes in breast cancer, cervical cancer, and endometrial cancer, 7,8 but there was a high rate of false-positives when used in patients with ovarian cancer. 9 In order to show ovarian tumours clearly by NIR fluorescence imaging during operation, some nanoparticle probes have been designed and achieved excellent results in basic experimental stage. 10–13 A Phase II clinical trial indicated that OTL38, which consists of folate conjugated to an indocyanine green-like (excitation at 776 nm, emission at 796 nm) near-infrared fluorescent dye termed S0456, was more effective in detecting tumours when using NIR fluorescent imaging during surgery. At least one additional lesion was detected in 48.3% of patients (14/29) by using OTL38-mediated near-infrared fluorescence imaging, but the tumour-to-background fluorescence signal ratio (TBR) of O -Abstract Truncated-